Hypoprolactinemia: Biology, Clinical Relevance, and Diagnostic Challenges
Clinical Endocrinology · 2026-03 · 104 (3) · 188-199
DOI: 10.1111/cen.70068 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Endocrinology, online erschienen am 02.12.2025. Verfasst von Rosa Maria Paragliola und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departmental Faculty of Medicine, Unicamillus-Saint Camillus International University of Health Sciences, Rome, Italy. Hauptthemen laut MEDLINE: Prolactin. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Background
Prolactin (PRL) is a pleiotropic hormone, traditionally associated with lactation, but now recognised for its role in reproduction, metabolism, and neuroendocrine and immune regulation. While the clinical features and consequences of hyperprolactinemia are well known, hypoprolactinemia is poorly understood.
Results
The causes of PRL deficiency range from genetic mutation to acquired pituitary diseases and rare isolated disorders. Its diagnostic evaluation is often challenging, due to the lack of standardised lower reference limits. Nonetheless, growing evidence links hypoprolactinemia not only to postpartum agalactia, but also to reproductive and sexual dysfunction, and to metabolic alterations and increased cardiometabolic risk. Data from animal models and rare human cases further suggest that PRL exerts unique biological functions that are not fully compensated by other pituitary hormones. PRL measurement, when interpreted alongside gonadotropin levels and clinical context, may help in the differential diagnosis of secondary amenorrhoea. Markedly low PRL levels—especially in association with hypogonadotropic profiles—may support a diagnosis of functional hypothalamic amenorrhoea.
Conclusions
PRL should be recognised as a hormone whose deficiency may cause broader systemic disturbances. A comprehensive understanding of hypoprolactinemia is essential to better define its diagnostic criteria and clinical significance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departmental Faculty of Medicine, Unicamillus-Saint Camillus International University of Health Sciences, Rome, Italy.
- Unit of Endocrine Surgery, Ospedale Isola Tiberina-Gemelli Isola, Rome, Italy.
- Unit of Endocrinology, Department of Translational Medicine and Surgery, Fondazione Policlinico "A. Gemelli" IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
- Department of Neurological Sciences, Neurosurgery, "La Sapienza" University of Rome, Rome, Italy.
- Division of Endocrinology, Diabetes and Metabolism and Pituitary Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Rosa Maria Paragliola, Gianluca Cera
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Paragliola, R. M., Corsello, A., Cera, G., Locantore, P., Piccirilli, M., & Salvatori, R. (2026). Hypoprolactinemia: Biology, Clinical Relevance, and Diagnostic Challenges. Clinical Endocrinology, 104(3), 188-199. https://doi.org/10.1111/cen.70068
Vancouver
Paragliola RM, Corsello A, Cera G, Locantore P, Piccirilli M, Salvatori R. Hypoprolactinemia: Biology, Clinical Relevance, and Diagnostic Challenges. Clinical Endocrinology. 2026;104(3):188-199. doi:10.1111/cen.70068
BibTeX
@article{Paragliola2026,
author = {Paragliola, Rosa Maria and Corsello, Andrea and Cera, Gianluca and Locantore, Pietro and Piccirilli, Manolo and Salvatori, Roberto},
title = {Hypoprolactinemia: Biology, Clinical Relevance, and Diagnostic Challenges},
journal = {Clinical Endocrinology},
year = {2026},
volume = {104},
number = {3},
pages = {188--199},
doi = {10.1111/cen.70068}
}
EUVIMED